- In April 2024, Medtronic launched its next-generation robot‑assisted cardiac surgery platform in select North American and European hospitals. Designed for minimally invasive heart procedures, the system promises greater precision, shorter operating times, and improved real‑time imaging—reinforcing Medtronic’s leadership in intelligent surgical automation
- In March 2024, Intuitive announced a strategic collaboration with university hospitals in Germany to pilot an AI‑integrated version of its latest da Vinci 5 robotic surgery platform for cardiac use. The software enhances surgery planning through machine learning and predictive analytics to optimize cardiology interventions
- In Feb 2024, Stryker introduced a navigation‑enabled robotic cardiothoracic surgery simulator for training institutions in the Asia‑Pacific region. This system provides simulation for mitral valve repair and coronary artery bypass procedures using robotic precision, showcasing Stryker’s commitment to innovation and surgical education
- In January 2024, Zimmer Biomet received FDA 510(k) clearance for its VersaCardio Robotic System, intended for minimally invasive heart valve surgeries. The platform combines robotics, real‑time imaging, and haptic feedback, positioning Zimmer Biomet as an emerging contender in robotic cardiology. Clinical deployment is expected in Q3 2024
- In December 2023, Siemens Healthineers expanded its cardiac robotics R&D hub in Bangalore, India, investing approximately INR 3,600 crore (~USD 45 million). The facility will focus on developing robotic systems for interventional cardiology and catheter-based procedures to serve emerging APAC markets
